for-phone-onlyfor-tablet-portrait-upfor-tablet-landscape-upfor-desktop-upfor-wide-desktop-up

BRIEF-First Patient Dosed In Pivotal Phase 3 Trial Of SNF472 In Calciphylaxis

Feb 13 (Reuters) -

* FIRST PATIENT DOSED IN PIVOTAL PHASE 3 TRIAL OF SNF472 IN CALCIPHYLAXIS Source text for Eikon:

for-phone-onlyfor-tablet-portrait-upfor-tablet-landscape-upfor-desktop-upfor-wide-desktop-up